Developer docs
API playgroundTry for free, no card

Search company profiles

CorDx

Full company profile

uuid0005qm5

Namestring
CorDx
Websiteurl
cordx.com
Company typeenum
Private
Founded yearint
2006
Short descriptiontext

CorDx is a privately held US medical device company headquartered in Atlanta, founded in 2006, that supplies medical device solutions to the healthcare industry and employs between 1,001 and 5,000 people.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAlpharetta, United States
HQ citystring
Alpharetta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical device solutions, healthcare diagnostics, in-vitro diagnostics, clinical diagnostic devices, medical equipment manufacturing
Industry2 codes
PRIMARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYIMALAIAD
Medical Device Packaging (Trays, Clamshells, Kits)
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing33911
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices
Social media profiles2 records
Cost components5 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CorDx supplies medical device solutions to the healthcare industry. The company focuses on delivering physical medical-device products to healthcare-sector buyers. Detailed product breakdowns, technical specifications, and customer success metrics are not provided in the available source material.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeBroad incumbent
Description

Bio-Rad is a diversified life-science and diagnostics manufacturer whose IVD product lines (including rapid infectious-disease tests) overlap with CorDx's core focus while serving a much broader customer base.

TypeDirect peer
Description

ACON Laboratories manufactures rapid diagnostic tests (Flowflex, Mission) across infectious disease, drugs of abuse, and women's health, directly competing with CorDx in lateral-flow assay products.

TypeBroad incumbent
Description

BD produces the Veritor rapid testing platform plus a broad diagnostics and life-science portfolio, directly competing with CorDx in rapid infectious-disease and point-of-care diagnostics.

4GenBody
TypeDirect peer
Description

GenBody is an Asian-headquartered rapid diagnostic manufacturer with global OEM and branded distribution, comparable to CorDx in manufacturing footprint and product category.

TypeDirect peer
Description

OraSure Technologies manufactures rapid diagnostic tests including OraQuick for HIV and HCV, directly comparable to CorDx's infectious-disease rapid-test portfolio and global distribution model.

TypeDirect peer
Description

Access Bio manufactures rapid immunochromatographic assays including CareStart-branded tests, directly competing with CorDx in the global lateral-flow diagnostics category.

7CTK Biotech
TypeDirect peer
Description

CTK Biotech manufactures rapid IVD tests for infectious diseases and women's health, directly competing with CorDx in lateral-flow assay products globally.

8LumiraDx
TypeDirect peer
Description

LumiraDx produces a microfluidic rapid-testing platform used across multiple disease states, comparable in focus to CorDx's rapid-IVD positioning and the kind of distribution-led model CorDx operates.

9Abbott
TypeBroad incumbent
Description

Abbott Diagnostics produces the BinaxNOW and Panbio rapid antigen tests and operates one of the largest IVD businesses globally, making it a broad incumbent peer overlapping with CorDx's rapid-test focus.

TypeDirect peer
Description

QuidelOrtho is a leading manufacturer of rapid diagnostic tests including the Sofia and Triage platforms, directly overlapping CorDx's core market of point-of-care IVD assays.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CorDx

Medical Devicescordx.com

CorDx is a privately held US medical device company headquartered in Atlanta, founded in 2006, that supplies medical device solutions to the healthcare industry and employs between 1,001 and 5,000 people.

CorDx firmographics

Firmographics
Name
CorDx
Website
https://cordx.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
51–100 employees
Short description
CorDx is a privately held US medical device company headquartered in Atlanta, founded in 2006, that supplies medical device solutions to the healthcare industry and employs between 1,001 and 5,000 people.
Ownership category
akta.pro rank

CorDx industry classification

Industry
Product category
Medical Devices
NAICS
Medical Equipment and Supplies Manufacturing (33911)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYIMALAIAD
Medical Device Packaging (Trays, Clamshells, Kits)

Keywords

  • Medical device solutions
  • Healthcare diagnostics
  • In-vitro diagnostics
  • Clinical diagnostic devices
  • Medical equipment manufacturing

Where CorDx is headquartered

Location

Headquarters

HQ city
Alpharetta
HQ country
United States
HQ region
North America

Markets served

CorDx business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

CorDx product offering

Product offering

Core offering

CorDx supplies medical device solutions to the healthcare industry. The company focuses on delivering physical medical-device products to healthcare-sector buyers. Detailed product breakdowns, technical specifications, and customer success metrics are not provided in the available source material.

Differentiator

Problem solved

Functional benefit

Companies that use CorDx

Customer profile

Ideal customer profiles1 record

CorDx technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CorDx competitors and assessment

Company assessment

Broad incumbents

  • Bio-Rad Laboratories: Bio-Rad is a diversified life-science and diagnostics manufacturer whose IVD product lines (including rapid infectious-disease tests) overlap with CorDx's core focus while serving a much broader customer base.
  • Becton Dickinson (BD): BD produces the Veritor rapid testing platform plus a broad diagnostics and life-science portfolio, directly competing with CorDx in rapid infectious-disease and point-of-care diagnostics.
  • Abbott: Abbott Diagnostics produces the BinaxNOW and Panbio rapid antigen tests and operates one of the largest IVD businesses globally, making it a broad incumbent peer overlapping with CorDx's rapid-test focus.

Direct peers

  • ACON Laboratories: ACON Laboratories manufactures rapid diagnostic tests (Flowflex, Mission) across infectious disease, drugs of abuse, and women's health, directly competing with CorDx in lateral-flow assay products.
  • GenBody: GenBody is an Asian-headquartered rapid diagnostic manufacturer with global OEM and branded distribution, comparable to CorDx in manufacturing footprint and product category.
  • OraSure Technologies: OraSure Technologies manufactures rapid diagnostic tests including OraQuick for HIV and HCV, directly comparable to CorDx's infectious-disease rapid-test portfolio and global distribution model.
  • Access Bio: Access Bio manufactures rapid immunochromatographic assays including CareStart-branded tests, directly competing with CorDx in the global lateral-flow diagnostics category.
  • CTK Biotech: CTK Biotech manufactures rapid IVD tests for infectious diseases and women's health, directly competing with CorDx in lateral-flow assay products globally.
  • LumiraDx: LumiraDx produces a microfluidic rapid-testing platform used across multiple disease states, comparable in focus to CorDx's rapid-IVD positioning and the kind of distribution-led model CorDx operates.
  • QuidelOrtho: QuidelOrtho is a leading manufacturer of rapid diagnostic tests including the Sofia and Triage platforms, directly overlapping CorDx's core market of point-of-care IVD assays.

Market position

Customer concentration

CorDx social profiles

Digital presence

CorDx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CorDx leadership team

Management profile

Number of profiles

CorDx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CorDx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CorDx

What does CorDx do?

CorDx supplies medical device solutions to the healthcare industry. The company focuses on delivering physical medical-device products to healthcare-sector buyers. Detailed product breakdowns, technical specifications, and customer success metrics are not provided in the available source material.

When was CorDx founded?

CorDx was founded in 2006. It employs 51 to 100 people.

Where is CorDx based?

CorDx is headquartered in Alpharetta, United States, in the North America region.

Who are CorDx's main competitors?

Broad incumbents on record are Bio-Rad Laboratories, Becton Dickinson (BD) and Abbott. Direct peers are ACON Laboratories, GenBody, OraSure Technologies, Access Bio, CTK Biotech, LumiraDx and QuidelOrtho.

Does CorDx have an API?

No public API is recorded for CorDx.

What industry is CorDx in?

CorDx's product category is Medical Devices. Its primary akta.pro industry code is CRADAMAK, Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests), with a secondary code of IMALAIAD, Medical Device Packaging (Trays, Clamshells, Kits). Its NAICS code is 33911 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCorDx COVID-19 Antigen Test Receives Approval for Use in SingaporeCorDx received approval from Singapore's Health Sciences Authority for its COVID-19 Antigen Test, which is designed for non-prescription home use with a 10-minute result time. This regulatory milestone follows the company's announcement in January 2023 to establish an Asia-Pacific business development center and R&D laboratory in Singapore.PR NewswireCorDx Receives FDA Emergency Use Authorization for COVID-19 Antigen TestCorDx, a diagnostics and medical device company headquartered in Atlanta, received Emergency Use Authorization from the U.S. Food and Drug Administration for its COVID-19 Antigen Test designed for non-prescription home use with a 10-minute time to result. The test is a lateral flow immunoassay device for qualitative detection of SARS-CoV-2 antigen, authorized only for the duration of the COVID-19 public health emergency declaration. CorDx stated it aims to leverage its integrated supply chain to provide affordable diagnostic products to families in the United States.PR NewswireCE Mark Applied to CorDx's Latest Monkeypox Diagnostic TestCorDx has applied for and received CE Mark certification for its third monkeypox diagnostic test, enabling the company to market all three of its monkeypox tests in the European Union. The CE Mark is the EU's mandatory conformity marking for goods sold within the European Economic Area. The WHO declared monkeypox a public health emergency of international concern on July 23, 2022, increasing global attention on diagnostic solutions for the virus.PR NewswireCorDx Granted CE Mark for Two Monkeypox Diagnostic TestsCorDx, a diagnostics company headquartered in Atlanta, Georgia, was granted CE Mark certification on May 23, 2022, for two monkeypox diagnostic tests, enabling the company to market these tests in the European Union. The two tests include a Monkeypox Virus Fluorescence PCR Kit for nucleic acid detection and a Monkeypox Virus IgM/IgG Ab Test for antibody detection. The certification comes amid the WHO declaring monkeypox a public health emergency of international concern on July 23, 2022.PR NewswireCorDx Granted CE Mark for World's First Combo Influenza, RSV, COVID-19 Self-TestCorDx, a diagnostics company headquartered in Atlanta, has received CE Mark certification for what it claims is the world's first self-test that simultaneously detects influenza A, influenza B, COVID-19, and respiratory syncytial virus (RSV). The certification allows CorDx to market the combo test across the European Union, targeting families and healthcare providers. The company cited rising respiratory infections as COVID-19 prevention measures relax globally as a key driver for introducing the diagnostic tool.